Cargando…
Exploiting TLK1 and Cisplatin Synergy for Synthetic Lethality in Androgen-Insensitive Prostate Cancer
Cellular organisms possess intricate DNA damage repair and tolerance pathways to manage various DNA lesions arising from endogenous or exogenous sources. The dysregulation of these pathways is associated with cancer development and progression. Synthetic lethality (SL), a promising cancer therapy co...
Autores principales: | Bhoir, Siddhant, Ogundepo, Oluwatobi, Yu, Xiuping, Shi, Runhua, De Benedetti, Arrigo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669050/ https://www.ncbi.nlm.nih.gov/pubmed/38001987 http://dx.doi.org/10.3390/biomedicines11112987 |
Ejemplares similares
-
Generation of Phenothiazine with Potent Anti-TLK1 Activity for Prostate Cancer Therapy
por: Singh, Vibha, et al.
Publicado: (2020) -
Targeting the TLK1/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors
por: Singh, Vibha, et al.
Publicado: (2019) -
Targeting Prostate Cancer, the ‘Tousled Way’
por: Bhoir, Siddhant, et al.
Publicado: (2023) -
The TLK1–MK5 Axis Regulates Motility, Invasion, and Metastasis of Prostate Cancer Cells
por: Khalil, Md Imtiaz, et al.
Publicado: (2022) -
Tousled kinase TLK1B mediates chromatin assembly in conjunction with Asf1 regardless of its kinase activity
por: De Benedetti, Arrigo
Publicado: (2010)